Dr. Sharon E. Crane

Country/Region of practice
United States
Pronouns:
She/her/her
About me
Sharon E. Crane, Ph.D. is the Chair of FICPI’s working group on Biotechnology and Pharmaceuticals (CET5).  She is a partner at the firm of Rothwell, Figg, Ernst & Manbeck, PC in Washington DC, and is active in patent post-grant procedures, patent interferences, prosecution and litigation.
Academic Qualifications

Ph.D. in Molecular Biology and Genetics from Johns Hopkins School of Medicine

JD from George Washington School of Law.

Social Media

Roles in FICPI

  • CET 5 Biotechnology and Pharmaceuticals

    CET Group 5 is dedicated to following, reporting and providing substantive comments and opinions on emerging issues relating to the patenting and regulatory affairs in the Biotechnology and Pharmaceutical fields. 

    In addition, CET 5 is closely following developments related to genetic resources and developing requirements for notice on their country of origin.  Prominent issues CET 5 addresses regarding patenting in these technological fields include subject matter eligibility, and in particular, the patentability of chemical/biological inventions developed using machines, computer implementation and/or artificial intelligence.  CET 5 supports FICPI in its mission to be an international leader promoting patent protection in the biotechnology and pharmaceutical arts.

  • Chair
Languages
  • English
CONTACT MEMBER